Cardiac autonomic nervous system activity in obese and never-obese young men.
Autonomic nervous system (ANS) activity in age-matched, weight-stable, free-living, ad libitum-fed, obese (OB) and never-obese (NO) young men (body mass index means [SD], 38.5 [3.9] and 22.0 [1.7], respectively) was evaluated by sequential blockade of cardiac autonomic innervation with weight-adjusted doses of parasympathetic (atropine) and sympathetic (esmolol) blockers so as to produce maximal effects on heart rate. Change in heart period (interbeat interval) from baseline, induced by atropine, defined parasympathetic control (PC), and the subsequent change, after esmolol administration, defined sympathetic control (SC). The heart period, after PC and SC blockade, defined intrinsic heart period (I). In the OB group, baseline heart period and PC were lower, and SC and I were higher, than in the NO group. The results in the OB, relative to the NO subjects, are similar to those reported in a previous study of NO subjects who had undergone a 10% weight gain by overfeeding. These findings suggest that the ANS of individuals with obesity is chronically altered in a way that would tend to oppose their excessive adiposity, and that these autonomic changes are more likely to be responses to other forces that induce obesity, rather than being primary agents in the production of the disease.
Arrone
L J
LJ
Laboratory of Human Behavior and Metabolism, Rockefeller University, New York, NY 10021-6399, USA.
Mackintosh
R
R
Rosenbaum
M
M
Leibel
R L
RL
Hirsch
J
J
D000328:Adult; D001285:Atropine; D001341:Autonomic Nervous System / Q000503:physiopathology*; D004562:Electrocardiography; D006321:Heart / Q000294:innervation*; D006801:Humans; D008297:Male; D009765:Obesity / Q000503:physiopathology*; D010276:Parasympatholytics; D011412:Propanolamines; D013565:Sympatholytics
D010276:Parasympatholytics; D011412:Propanolamines; D013565:Sympatholytics; D001285:Atropine; C036604:esmolol